Heteroaromatic pentacyclic compound and medicinal use thereof

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/12 (2006.01) A61K 31/381 (2006.01) A61K 31/405 (2006.01) A61K 31/4155 (2006.01) A61K 31/4184 (2006.01) A61K 31/421 (2006.01) A61K 31/423 (2006.01) A61K 31/427 (2006.01) A61K 31/428 (2006.01) A61K 31/4439 (2006.01) A61K 31/4725 (2006.01) A61K 31/497 (2006.01) A61K 31/538 (2006.01) A61K 45/00 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) A61P 43/00 (2006.01) C07D 263/32 (2006.01) C07D 277/22 (2006.01) C07D 277/28 (2006.01) C07D 333/16 (2006.01) C07D 333/18 (2006.01) C07D 333/2

Patent

CA 2521830

A heteroaromatic pentacyclic compound of the general formula: [I] [wherein V is CH or N; W is S or O; each of R1 and R2 is H, etc.; X is -N(R4)-, -O-, -S-, -SO2-N(R5)-, -CO-N(R7)-, etc.; L is formula [II]; (Each of R20, R21, R22 and R25 is H, etc.; and E is an aryl or an aromatic heterocycle); R is -COOH, etc.; B is an aryl, etc.; R3 is H, etc.; Y is -C(R13)(R14)-N(R12)-, - C(R13)(R14)-O-, -N(R11)-, -O-, etc.; A is an alkylene; Z is an aryl, etc.; etc.]. This compound or its prodrug or a pharmaceutically acceptable salt thereof has a protein tyrosine phosphatase 1B inhibiting activity and is useful as a curative medicine for diabetes mellitus, diabetes mellitus complications, hyperlipemia or obesity.

L'intention concerne un composé pentacyclique hétéroaromatique représenté par la formule (I) [dans laquelle V représente CH ou N; W représente S ou O; chacun de R?1¿ et R?2¿ représentent H, etc.; X représente -N(R?4¿)-, -O-, -S-, -SO¿2?-N(R?5¿)-, -CO-N(R?7¿)-, etc.; L représente la formule (II) ; (Chacun de R?20¿, R?21¿, R?22 ¿et R?25¿ représente H, etc.; et E représente aryle ou hétérocycle aromatique); R représente -COOH, etc.; B représente aryle, etc.; R?3¿ représente H, etc.; Y représente -C(R?13¿) (R?14¿) -N(R?12¿)-, -C(R?13¿) (R?14¿)-O-, -N(R?11¿)-, -O-, etc.; A représente alkylène; Z représente aryle, etc.; etc.]. Ce composé ou son promédicament ou un sel pharmaceutiquement acceptable de celui-ci comprend une protéine tyrosine phosphatase 1B inhibant une activité et est utilisé comme médicament curatif pour les diabètes sucrés, les complications de diabète sucré, l'hyperlipémie ou l'obésité.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heteroaromatic pentacyclic compound and medicinal use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroaromatic pentacyclic compound and medicinal use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaromatic pentacyclic compound and medicinal use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1615309

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.